First published by Author on December 06, 2023 in the following categories: Consumer Law Industry Investigations Latest Pricing and tagged with cma | competition law | consumer law | investigations | market study | medical | Pharmaceuticals | pricing
In recent times, the issue of Hydrocortisone tablet pricing has garnered significant attention, prompting regulatory bodies to investigate alleged excessive and unfair pricing, anti-competitive agreements, and alleged abusive conduct within the pharmaceutical industry.
The Competition and Markets Authority (CMA) has been at the forefront of addressing these concerns, exemplified by its recent case which focuses on Hydrocortisone tablets.
In this article, we delve into the intricacies of the case, shedding light on key aspects of Hydrocortisone tablet pricing and the implications for the pharmaceutical industry.
First published by Author on October 05, 2022 in the following categories: Consumer Law Industry Investigations Latest Price Fixing Pricing and tagged with cma | competition law | consumer law | investigations | medical | price fixing | pricing
It is important for the CMA to look into incidents of suspected unfair pricing to ensure that consumers are not being overcharged and taken advantage of.
This can particularly be the case in relation to medication costs of which the CMA has looked into a number of issues about the NHS being overcharged, and we will provide an update of an example in this article.
Broadly speaking, it is important that pricing is set at fair levels and that companies are not taking advantage of consumers to drive their profits up in an obscene manner. At the same time, competition must be required to allow pricing to be set competitively as well.
According to a report from The Times newspaper, UK pharmaceutical companies are reportedly paying millions of pounds to healthcare professionals and other organisations.
American pharmaceutical companies have previously come under fire for reportedly paying healthcare professionals to push their products, and it now appears the UK may have the same problem.